Home Applications 205382 Application 205382
Type NDA
Sponsor GLAXO GRP ENGLAND Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 INCRUSE ELLIPTA UMECLIDINIUM BROMIDE POWDER;INHALATION EQ 62.5MCG BASE/INH Yes Yes
Source provenance: Browse the complete Orange Book source catalog · source snapshot 43 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N205382-001 INCRUSE ELLIPTA UMECLIDINIUM BROMIDE EQ 0.0625MG BASE/INH POWDER / INHALATION RLD, RS 2014-04-30
Orange Book patents# Current patent rows page 1 of 1 · 1 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N205382-001 7488827 2027-12-18 Drug substance, Drug product 2014-05-21
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 43 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-09-14 22:38:34 2026-08 N205382-001 INCRUSE ELLIPTA EQ 0.0625MG BASE/INH POWDER / INHALATION RLD, RS 2014-04-30 84e616aacf4f…2026-08-18 06:07:40 2026-07 N205382-001 INCRUSE ELLIPTA EQ 0.0625MG BASE/INH POWDER / INHALATION RLD, RS 2014-04-30 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N205382-001 INCRUSE ELLIPTA EQ 0.0625MG BASE/INH POWDER / INHALATION RLD, RS 2014-04-30 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N205382-001 INCRUSE ELLIPTA EQ 0.0625MG BASE/INH POWDER / INHALATION RLD, RS 2014-04-30 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N205382-001 INCRUSE ELLIPTA EQ 0.0625MG BASE/INH POWDER / INHALATION RLD, RS 2014-04-30 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N205382-001 INCRUSE ELLIPTA EQ 0.0625MG BASE/INH POWDER / INHALATION RLD, RS 2014-04-30 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N205382-001 INCRUSE ELLIPTA EQ 0.0625MG BASE/INH POWDER / INHALATION RLD, RS 2014-04-30 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N205382-001 INCRUSE ELLIPTA EQ 0.0625MG BASE/INH POWDER / INHALATION RLD, RS 2014-04-30 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N205382-001 INCRUSE ELLIPTA EQ 0.0625MG BASE/INH POWDER / INHALATION RLD, RS 2014-04-30 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N205382-001 INCRUSE ELLIPTA EQ 0.0625MG BASE/INH POWDER / INHALATION RLD, RS 2014-04-30 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N205382-001 INCRUSE ELLIPTA EQ 0.0625MG BASE/INH POWDER / INHALATION RLD, RS 2014-04-30 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N205382-001 INCRUSE ELLIPTA EQ 0.0625MG BASE/INH POWDER / INHALATION RLD, RS 2014-04-30 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N205382-001 INCRUSE ELLIPTA EQ 0.0625MG BASE/INH POWDER / INHALATION RLD, RS 2014-04-30 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N205382-001 INCRUSE ELLIPTA EQ 0.0625MG BASE/INH POWDER / INHALATION RLD, RS 2014-04-30 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N205382-001 INCRUSE ELLIPTA EQ 0.0625MG BASE/INH POWDER / INHALATION RLD, RS 2014-04-30 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N205382-001 INCRUSE ELLIPTA EQ 0.0625MG BASE/INH POWDER / INHALATION RLD, RS 2014-04-30 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N205382-001 INCRUSE ELLIPTA EQ 62.5MCG BASE/INH POWDER / INHALATION RLD, RS 2014-04-30 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N205382-001 INCRUSE ELLIPTA EQ 62.5MCG BASE/INH POWDER / INHALATION RLD, RS 2014-04-30 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N205382-001 INCRUSE ELLIPTA EQ 62.5MCG BASE/INH POWDER / INHALATION RLD, RS 2014-04-30 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 N205382-001 INCRUSE ELLIPTA EQ 62.5MCG BASE/INH POWDER / INHALATION RLD, RS 2014-04-30 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 N205382-001 INCRUSE ELLIPTA EQ 62.5MCG BASE/INH POWDER / INHALATION RLD, RS 2014-04-30 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 N205382-001 INCRUSE ELLIPTA EQ 62.5MCG BASE/INH POWDER / INHALATION RLD, RS 2014-04-30 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N205382-001 INCRUSE ELLIPTA EQ 62.5MCG BASE/INH POWDER / INHALATION RLD, RS 2014-04-30 87673890dc5c…2021-03-12 10:30 UTC 2021-03 N205382-001 INCRUSE ELLIPTA EQ 62.5MCG BASE/INH POWDER / INHALATION RLD, RS 2014-04-30 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 N205382-001 INCRUSE ELLIPTA EQ 62.5MCG BASE/INH POWDER / INHALATION RLD, RS 2014-04-30 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 N205382-001 INCRUSE ELLIPTA EQ 62.5MCG BASE/INH POWDER / INHALATION RLD, RS 2014-04-30 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 N205382-001 INCRUSE ELLIPTA EQ 62.5MCG BASE/INH POWDER / INHALATION RLD, RS 2014-04-30 3f01610625f2…2019-09-15 20:21 UTC 2019-09 N205382-001 INCRUSE ELLIPTA EQ 62.5MCG BASE/INH POWDER / INHALATION RLD, RS 2014-04-30 b00525d2431f…2019-07-19 19:46 UTC 2019-07 N205382-001 INCRUSE ELLIPTA EQ 62.5MCG BASE/INH POWDER / INHALATION RLD, RS 2014-04-30 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N205382-001 INCRUSE ELLIPTA EQ 0.0625MG BASE/INH POWDER / INHALATION RLD, RS 2014-04-30 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 N205382-001 INCRUSE ELLIPTA EQ 0.0625MG BASE/INH POWDER / INHALATION RLD, RS 2014-04-30 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 N205382-001 INCRUSE ELLIPTA EQ 62.5MCG BASE/INH POWDER / INHALATION RLD, RS 2014-04-30 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 N205382-001 INCRUSE ELLIPTA EQ 62.5MCG BASE/INH POWDER / INHALATION RLD, RS 2014-04-30 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 N205382-001 INCRUSE ELLIPTA EQ 62.5MCG BASE/INH POWDER / INHALATION RLD, RS 2014-04-30 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 N205382-001 INCRUSE ELLIPTA EQ 62.5MCG BASE/INH POWDER / INHALATION RLD, RS 2014-04-30 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 N205382-001 INCRUSE ELLIPTA EQ 62.5MCG BASE/INH POWDER / INHALATION RLD, RS 2014-04-30 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 N205382-001 INCRUSE ELLIPTA EQ 62.5MCG BASE/INH POWDER / INHALATION RLD, RS 2014-04-30 053a50430f4f…2023-01-26 05:58 UTC 2023-01 N205382-001 INCRUSE ELLIPTA EQ 62.5MCG BASE/INH POWDER / INHALATION RLD, RS 2014-04-30 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N205382-001 INCRUSE ELLIPTA EQ 62.5MCG BASE/INH POWDER / INHALATION RLD, RS 2014-04-30 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 N205382-001 INCRUSE ELLIPTA EQ 62.5MCG BASE/INH POWDER / INHALATION RLD, RS 2014-04-30 f41ea6bd6efb…
Observed Orange Book patent history# Patent history page 1 of 9 · 346 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-09-14 22:38:34 2026-08 N205382-001 7488827 2027-12-18 Drug substance, Drug product 2014-05-21 84e616aacf4f…2026-08-18 06:07:40 2026-07 N205382-001 7488827 2027-12-18 Drug substance, Drug product 2014-05-21 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N205382-001 7488827 2027-12-18 Drug substance, Drug product 2014-05-21 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N205382-001 7498440 2025-04-27 Drug substance, Drug product 2014-05-21 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N205382-001 8309572 2025-04-27 U-1476 2014-05-21 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N205382-001 8183257 2025-07-27 U-1476 2014-05-21 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N205382-001 7488827 2027-12-18 Drug substance, Drug product 2014-05-21 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N205382-001 7498440 2025-04-27 Drug substance, Drug product 2014-05-21 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N205382-001 8309572 2025-04-27 U-1476 2014-05-21 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N205382-001 8183257 2025-07-27 U-1476 2014-05-21 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N205382-001 7488827 2027-12-18 Drug substance, Drug product 2014-05-21 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N205382-001 7498440 2025-04-27 Drug substance, Drug product 2014-05-21 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N205382-001 8309572 2025-04-27 U-1476 2014-05-21 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N205382-001 8183257 2025-07-27 U-1476 2014-05-21 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N205382-001 9333310 2027-10-02 Drug product 2016-05-20 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N205382-001 7488827 2027-12-18 Drug substance, Drug product 2014-05-21 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N205382-001 8201556 2029-02-05 Drug product 2014-05-21 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N205382-001 8746242 2030-10-11 Drug product 2014-06-26 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N205382-001 7498440 2025-04-27 Drug substance, Drug product 2014-05-21 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N205382-001 8309572 2025-04-27 U-1476 2014-05-21 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N205382-001 8183257 2025-07-27 U-1476 2014-05-21 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N205382-001 9333310 2027-10-02 Drug product 2016-05-20 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N205382-001 7488827 2027-12-18 Drug substance, Drug product 2014-05-21 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N205382-001 8201556 2029-02-05 Drug product 2014-05-21 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N205382-001 8746242 2030-10-11 Drug product 2014-06-26 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N205382-001 7498440 2025-04-27 Drug substance, Drug product 2014-05-21 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N205382-001 8309572 2025-04-27 U-1476 2014-05-21 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N205382-001 8183257 2025-07-27 U-1476 2014-05-21 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N205382-001 9333310 2027-10-02 Drug product 2016-05-20 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N205382-001 7488827 2027-12-18 Drug substance, Drug product 2014-05-21 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N205382-001 8201556 2029-02-05 Drug product 2014-05-21 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N205382-001 8746242 2030-10-11 Drug product 2014-06-26 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N205382-001 7498440 2025-04-27 Drug substance, Drug product 2014-05-21 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N205382-001 8309572 2025-04-27 U-1476 2014-05-21 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N205382-001 8183257 2025-07-27 U-1476 2014-05-21 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N205382-001 9333310 2027-10-02 Drug product 2016-05-20 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N205382-001 7488827 2027-12-18 Drug substance, Drug product 2014-05-21 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N205382-001 8201556 2029-02-05 Drug product 2014-05-21 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N205382-001 8746242 2030-10-11 Drug product 2014-06-26 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N205382-001 7498440 2025-04-27 Drug substance, Drug product 2014-05-21 5bbf6a4d5a75…
Observed Orange Book exclusivity history# openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 2 matching rows.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application# NDC listings for this application page 1 of 1 · 9 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 0173-0873 Incruse Ellipta umeclidinium GlaxoSmithKline LLC NDA Current 0173-0873 Incruse Ellipta umeclidinium GlaxoSmithKline LLC NDA Current 0173-0873 Incruse Ellipta umeclidinium GlaxoSmithKline LLC NDA Current 0173-0873 Incruse Ellipta umeclidinium GlaxoSmithKline LLC NDA Current 0173-0873 Incruse Ellipta umeclidinium GlaxoSmithKline LLC NDA Current 0173-0873 Incruse Ellipta umeclidinium GlaxoSmithKline LLC NDA Current 0173-0873 Incruse Ellipta umeclidinium GlaxoSmithKline LLC NDA Current 0173-0873 Incruse Ellipta umeclidinium GlaxoSmithKline LLC NDA Current 0173-0873 Incruse Ellipta umeclidinium GlaxoSmithKline LLC NDA Current